Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose vs prandial insulin for gestational diabetes mellitus
2016-001986-10Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2016
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acarbose in gestational diabetes mellitus (GDM) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Composite perinatal complications. Started Aug 2016; status: completed.
02
Drugs
acarbose
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2016-001986-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001986-10.